Glabellar hemangioma

Known as: Capillary hemangioma (glabellar), Glabellar capillary hemangioma 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2016
02419722016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial… (More)
  • table 1
  • table 2
Is this relevant?
2007
2007
INTRODUCTION Botulinum toxin type A (BTX-A) has demonstrated impressive safety and efficacy for the treatment of dynamic facial… (More)
Is this relevant?
2007
2007
BACKGROUND Because well-controlled studies examining the efficacy and safety of various dilutions of botulinum toxin type A (BTX… (More)
Is this relevant?
2007
2007
BACKGROUND Global patient-reported outcomes do not evaluate specific aspects of treatment that are important to patients… (More)
Is this relevant?
2007
2007
BACKGROUND Patient satisfaction is a key measure of success when using botulinum toxin type A to treat glabellar rhytides… (More)
Is this relevant?
2005
2005
OBJECTIVE To compare the efficacy, safety, and duration of effect of four doses of botulinum toxin type A in the treatment of… (More)
Is this relevant?
2005
2005
BACKGROUND A single intramuscular treatment with botulinum toxin A (BoNT-A) into the facial muscles underlying glabellar rhytids… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
Plastic surgeons frequently administer botulinum toxin A (Botox) or collagen as monotherapy to treat glabellar furrows. This… (More)
Is this relevant?
2003
2003
BACKGROUND Over the past 15 years, BTX-A has become the standard treatment for dynamic glabellar furrowing. Some individuals have… (More)
Is this relevant?
2003
2003
During the last decade, the aesthetic use of botulinum toxin type A has risen dramatically. Because of the tremendous growth in… (More)
  • figure 1
Is this relevant?